天然杀手细胞免疫疗法对抗多形质母细胞瘤的潜在分子标
Luke C Cooksey1,2, Derek C Friesen1, Enrique D Mangan1
1Texas College of Osteopathic Medicine, University of North Texas Health Science Center, Fort Worth, TX 76107, USA.
Cells
|September 27, 2024
概括
多形质母细胞瘤 (GBM) 免疫疗法使用自然杀手 (NK) 细胞显示出前景. 研究人员审查了常见的NK细胞标,并提出了莱克样转录1 (LLT1) 和细胞表面增殖细胞核抗原 (csPCNA) 作为新的标.
科学领域:
- 神经瘤学神经瘤学
- 免疫学 免疫学 免疫学
- 癌症治疗 癌症治疗
背景情况:
- 多形质母细胞瘤 (GBM) 是一种具有较低生存率的侵袭性原发性脑瘤.
- 目前的GBM治疗方法包括手术,放射和化疗,其生存益处有限.
- 免疫疗法正在成为治疗各种癌症的有希望的策略,包括GBM.
研究的目的:
- 审查目前针对GBM的NK细胞免疫疗法目标.
- 探索增强NK细胞介导的GBM治疗的新目标.
- 突出NK细胞疗法在克服GBM治疗耐药性的潜力.
主要方法:
- 对GBM中已确定的和潜在的NK细胞点的文献综述.
- 对与NK细胞识别相关的瘤相关抗原 (TAA) 的分析.
- 在GBM中确定NK细胞向的新型表面标记物.
主要成果:
- 在NK细胞治疗中常被研究的GBM标包括EGFR,HER2,CD155和IL-13Rα2.2.
- NK细胞疗法提供多种方法,如单克隆抗体,CAR-NK细胞和BiKEs.
- 建议LLT1和csPCNA作为基于NK细胞的GBM免疫治疗的新目标.
结论:
- 基于NK细胞的免疫疗法代表了GBM治疗策略的重大进步.
- 针对GBM细胞的特定抗原可以增强NK细胞介导的瘤杀伤.
- 对LLT1和csPCNA的进一步调查可能会导致更有效的GBM免疫疗法.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
Cytotoxic T Cells-mediated Immune Response
858
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
858


